Fuji Pharma's net sales FY 2013-2021
In the fiscal year 2021, Fuji Pharma recorded net sales of almost 34 billion Japanese yen. Within the observed period, figures increased steadily every year until they peaked in fiscal 2018 at close to 38 billion yen.
The Japanese pharmaceutical company focuses on medical care for women, in vitro diagnostics, acute medical care products, and curative medicine.
The Japanese pharmaceutical company focuses on medical care for women, in vitro diagnostics, acute medical care products, and curative medicine.
